New Health Sciences

About:

New Health Sciences develops a technology to extend the shelf life of refrigerated red blood cells using novel storage methods.

Website: http://newhealthsciences.com

Twitter/X: NewHealthSci

Top Investors: National Institutes of Health, Omega Advisors

Description:

New Health Sciences is developing Hemanext, a technology designed to improve the safety and efficacy of transfusion therapy through novel storage methods potentially extending the shelf life of refrigerated red blood cells while improving their quality across the storage cycle. NHSi has financed development of the Hemanext technology through private investor funding and a series of NIH SBIR grants.